Table 4 Dosimetric results for OARs and non target tissues
Parameter | IMRT | IMPT | RA_HD120 | RA_M120 | p |
|---|---|---|---|---|---|
Rectum. Volume [cm3] 48.6 ± 17.6 [28.4-72.5] | |||||
D50 [Gy] | 10.1 ± 6.2 | 4.1 ± 4.0 | 8.2 ± 3.9 | 9.1 ± 4.2 | a,b,d,e,f |
D1 [Gy] | 49.6 ± 6.8 | 45.1 ± 9.2 | 45.2 ± 8.3 | 46.5 ± 7.8 | a,b,c |
V35 Gy [%] | 9.8 ± 5.3 | 3.9 ± 2.7 | 5.1 ± 3.0 | 5.9 ± 3.3 | a,b,c,e |
V45 Gy [%] | 3.6 ± 2.4 | 1.6 ± 1.3 | 1.6 ± 1.1 | 1.9 ± 1.3 | a,b,c |
Urethra. Volume [cm3] 0.7 ± 0.1 [0.6-0.8] | |||||
D50 [Gy] | 31.4 ± 13.1 | 26.8 ± 11.7 | 28.6 ± 11.4 | 28.6 ± 10.9 | a,b,c,d,e |
D1 [Gy] | 40.1 ± 3.3 | 38.1 ± 2.4 | 39.8 ± 3.5 | 39.3 ± 3.3 | a,c,d,f |
V35 Gy [%] | 60.7 ± 41.7 | 25.1 ± 21.1 | 38.0 ± 25.3 | 36.0 ± 24.0 | a,b,c |
V40 Gy [%] | 11.0 ± 12.8 | 0.6 ± 1.1 | 5.1 ± 5.4 | 4.0 ± 5.6 |  |
Left femoral head Volume [cm3] 60.1 ± 4.4 [54.8-67.6] | |||||
D50 [Gy] | 3.9 ± 2.6 | 0.1 ± 0.1 | 3.3 ± 2.1 | 3.5 ± 2.1 | a,b,d,e,f |
D1Gy] | 14.6 ± 7.2 | 2.3 ± 2.0 | 7.4 ± 1.5 | 7.6 ± 1.3 | a,b,c,d,e |
Right femoral head Volume [cm3] 60.9 ± 5.8 [54.6-71.6] | |||||
D50 [Gy] | 3.9 ± 2.7 | 0.1 ± 0.1 | 3.2 ± 2.3 | 3.4 ± 2.1 | a,d,e |
D1Gy] | 15.3 ± 7.5 | 2.5 ± 3.0 | 8.0 ± 1.8 | 8.0 ± 1.7 | a,b,c,d,e |
Bladder. Volume [cm3] 109.8 ± 63.6 [32.7-234.2] | |||||
D50 [Gy] | 4.9 ± 3.2 | 0.7 ± 0.9 | 4.6 ± 2.6 | 5.2 ± 3.0 | a,d,e,f |
D1 [Gy] | 42.3 ± 17.0 | 38.8 ± 19.6 | 41.3 ± 16.3 | 42.1 ± 15.8 |  |
V35 Gy [%] | 6.4 ± 6.3 | 3.9 ± 4.3 | 4.1 ± 4.1 | 4.5 ± 4.2 | a |
V50 Gy [%] | 1.9 ± 2.7 | 1.4 ± 2.1 | 1.3 ± 2.1 | 1.3 ± 2.1 |  |
Penile bulb. Volume [cm3] 7.2 ± 3.2 [3.0-13.2] | |||||
D50 [Gy] | 2.0 ± 1.5 | 0.9 ± 1.4 | 2.5 ± 1.7 | 3.2 ± 2.5 | a,b,c,d,e |
D1 [Gy] | 7.6 ± 9.4 | 7.1 ± 9.0 | 5.8 ± 4.6 | 7.7 ± 7.4 |  |
Non Target Tissue | |||||
Mean [Gy] | 2.0 ± 0.8 | 0.7 ± 0.3 | 1.8 ± 0.7 | 1.9 ± 0.7 | a,b,d,e,f |
V10 Gy [%] | 6.0 ± 2.6 | 2.8 ± 1.3 | 4.7 ± 2.5 | 5.1 ± 2.8 | a,b,c,d,e |
CI90 | 1.3 ± 0.1 | 1.6 ± 0.2 | 1.3 ± 0.1 | 1.3 ± 0.1 | a,d,e |
DoseInt [Gy*cm3 104] | 3.3 ± 1.6 | 1.1 ± 0.5 | 2.9 ± 1.3 | 3.1 ± 1.4 | a,b,d,e,f |